CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 31 - 40 of 830
Study Number Lead Group Study Title CIRB Study Status
S1011 SWOG A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer Adult CIRB - Late Phase Emphasis Available to Open
A041501 Alliance A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (A Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) with Newly Diagnosed Precursor B-Cell ALL Adult CIRB - Late Phase Emphasis Available to Open
WF-97415 NCORP-Wake Forest University Understanding and Predicting Breast Cancer Events after Treatment (UPBEAT) Cancer Prevention and Control CIRB Available to Open
ADVL18P1 COG An Open-Label Feasibility Study to Assess the Safety and Pharmacokinetics of Enasidenib in Pediatric Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML) with an Isocitrate Dehydrogenase-2 (IDH2) Mutation Pediatric CIRB Available to Open
10346 ETCTN Pilot Study of DS-8201a Pharmacodynamics in Patients with HER2-expressing Advanced Solid Tumors Adult CIRB - Early Phase Emphasis Available to Open
E2108 ECOG A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer Adult CIRB - Late Phase Emphasis Available to Open
EA6134 ECOG-ACRIN A Randomized Phase III trial of Dabrafenib + Trametinib followed by Ipilimumab + Nivolumab at Progression vs. Ipilimumab + Nivolumab followed by Dabrafenib + Trametinib at Progression in Patients With Advanced BRAFV600 Mutant Melanoma Adult CIRB - Late Phase Emphasis Available to Open
ALTE05N1 COG Umbrella Long-Term Follow-Up Protocol Pediatric CIRB Available to Open
AGCT1532 COG Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotheraphy for patients with intermediate and poor-risk metastatic germ cell tumours Pediatric CIRB Available to Open
ANBL17P1 COG A Pilot Induction Regimen Incorporating Chimeric 14.18 Antibody (ch14.18, dinutuximab) (NSC# 764038, IND# 4308) and Sargramostim (GM-CSF) for the Treatment of Newly Diagnosed High-Risk Neuroblastoma Pediatric CIRB Available to Open
Displaying 31 - 40 of 830